Etanercept to Treat Wegener's Granulomatosis

NCT00001901 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

NIH

Sponsor class

Conditions

Vasculitis
Wegener's Granulomatosis

Interventions

DRUG: Etanercept

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)